tradingkey.logo
tradingkey.logo

Cryoport Inc

CYRX
10.560USD
+0.060+0.57%
終値 01/09, 16:00ET15分遅れの株価
528.73M時価総額
8.38直近12ヶ月PER

Cryoport Inc

10.560
+0.060+0.57%

詳細情報 Cryoport Inc 企業名

Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.

Cryoport Incの企業情報

企業コードCYRX
会社名Cryoport Inc
上場日Jul 24, 2015
最高経営責任者「CEO」Shelton (Jerrell Wilson)
従業員数1090
証券種類Ordinary Share
決算期末Jul 24
本社所在地112 Westwood Place, Suite 350
都市BRENTWOOD
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号37027
電話番号19492321900
ウェブサイトhttps://www.cryoport.com/
企業コードCYRX
上場日Jul 24, 2015
最高経営責任者「CEO」Shelton (Jerrell Wilson)

Cryoport Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.00M
+25000.00%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
45.86K
+23214.00%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
44.90K
+23214.00%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
38.43K
+25000.00%
Mr. Robert S. Stefanovich
Mr. Robert S. Stefanovich
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
--
--
Mr. Edward J. Zecchini
Mr. Edward J. Zecchini
Senior Vice President, Chief Digital and Technology Officer
Senior Vice President, Chief Digital and Technology Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--
Mr. Ram M. Jagannath
Mr. Ram M. Jagannath
Independent Director
Independent Director
--
--
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Mr. Scott Eckstein
Mr. Scott Eckstein
Investor Relations
Investor Relations
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.00M
+25000.00%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
45.86K
+23214.00%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
44.90K
+23214.00%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
38.43K
+25000.00%
Mr. Robert S. Stefanovich
Mr. Robert S. Stefanovich
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
--
--
Mr. Edward J. Zecchini
Mr. Edward J. Zecchini
Senior Vice President, Chief Digital and Technology Officer
Senior Vice President, Chief Digital and Technology Officer
--
--

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Life Science products
19.98M
45.16%
BioLogistics solutions
19.43M
43.92%
BioStorage/Bioservices
4.83M
10.92%
地域別USD
会社名
収益
比率
Americas
33.14M
74.93%
Europe & Middle East & Africa (EMEA)
6.63M
15.00%
Asia Pacific
4.46M
10.07%
事業別
地域別
事業別USD
会社名
収益
比率
Life Science products
19.98M
45.16%
BioLogistics solutions
19.43M
43.92%
BioStorage/Bioservices
4.83M
10.92%

株主

更新時刻: Fri, Jan 2
更新時刻: Fri, Jan 2
株主統計
種類
株主統計
株主統計
比率
Cadian Capital Management LP
9.95%
Morgan Stanley & Co. LLC
9.11%
BlackRock Institutional Trust Company, N.A.
6.74%
The Vanguard Group, Inc.
5.71%
Brown Capital Management, LLC
5.24%
他の
63.25%
株主統計
株主統計
比率
Cadian Capital Management LP
9.95%
Morgan Stanley & Co. LLC
9.11%
BlackRock Institutional Trust Company, N.A.
6.74%
The Vanguard Group, Inc.
5.71%
Brown Capital Management, LLC
5.24%
他の
63.25%
種類
株主統計
比率
Investment Advisor
41.65%
Investment Advisor/Hedge Fund
25.48%
Hedge Fund
22.33%
Research Firm
11.05%
Individual Investor
3.99%
Bank and Trust
0.67%
Sovereign Wealth Fund
0.43%
Pension Fund
0.42%
Family Office
0.10%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
367
51.10M
102.06%
-7.68M
2025Q3
382
51.46M
118.49%
+897.37K
2025Q2
395
50.60M
125.22%
-144.83K
2025Q1
397
50.53M
128.31%
-13.51M
2024Q4
394
50.41M
130.61%
-180.77K
2024Q3
409
50.54M
130.03%
-5.26M
2024Q2
410
52.11M
125.57%
-2.50M
2024Q1
424
53.98M
124.33%
-7.14M
2023Q4
457
52.70M
119.71%
+4.70M
2023Q3
471
48.09M
113.05%
-102.80K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Cadian Capital Management LP
4.98M
9.95%
+14.84K
+0.30%
Sep 30, 2025
Morgan Stanley & Co. LLC
4.56M
9.11%
+12.81K
+0.28%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.38M
6.74%
-29.89K
-0.88%
Sep 30, 2025
The Vanguard Group, Inc.
2.86M
5.71%
+69.55K
+2.49%
Sep 30, 2025
Brown Capital Management, LLC
2.62M
5.24%
-1.18M
-30.99%
Sep 30, 2025
Millennium Management LLC
2.62M
5.23%
+408.33K
+18.46%
Sep 30, 2025
Fred Alger Management, LLC
1.78M
3.56%
-578.45K
-24.52%
Sep 30, 2025
Thematics Asset Management SAS
1.66M
3.32%
+1.04M
+168.96%
Mar 31, 2025
Natixis Investment Managers SA
1.64M
3.27%
-276.26K
-14.43%
Sep 30, 2025
Assenagon Asset Management S.A.
1.50M
2.99%
+408.26K
+37.44%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Invesco NASDAQ Future Gen 200 ETF
0.56%
Inspire Small/Mid Cap ESG ETF
0.21%
JPMorgan Fundamental Data Science Small Core ETF
0.1%
Avantis US Small Cap Equity ETF
0.05%
Vanguard US Momentum Factor ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Global X Russell 2000 ETF
0.02%
ProShares UltraPro Russell2000
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
ProShares Hedge Replication ETF
0.02%
詳細を見る
Invesco NASDAQ Future Gen 200 ETF
比率0.56%
Inspire Small/Mid Cap ESG ETF
比率0.21%
JPMorgan Fundamental Data Science Small Core ETF
比率0.1%
Avantis US Small Cap Equity ETF
比率0.05%
Vanguard US Momentum Factor ETF
比率0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.03%
Global X Russell 2000 ETF
比率0.02%
ProShares UltraPro Russell2000
比率0.02%
Invesco RAFI US 1500 Small-Mid ETF
比率0.02%
ProShares Hedge Replication ETF
比率0.02%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Cryoport Incの上位5名の株主は誰ですか?

Cryoport Incの上位5名の株主は以下のとおりです。
Cadian Capital Management LPは4.98M株を保有しており、これは全体の9.95%に相当します。
Morgan Stanley & Co. LLCは4.56M株を保有しており、これは全体の9.11%に相当します。
BlackRock Institutional Trust Company, N.A.は3.38M株を保有しており、これは全体の6.74%に相当します。
The Vanguard Group, Inc.は2.86M株を保有しており、これは全体の5.71%に相当します。
Brown Capital Management, LLCは2.62M株を保有しており、これは全体の5.24%に相当します。

Cryoport Incの株主タイプ上位3種は何ですか?

Cryoport Incの株主タイプ上位3種は、
Cadian Capital Management LP
Morgan Stanley & Co. LLC
BlackRock Institutional Trust Company, N.A.

Cryoport Inc(CYRX)の株式を保有している機関の数はいくつですか?

2025Q4時点で、Cryoport Incの株式を保有している機関は367社あり、保有株式の総市場価値は約51.10Mで、全体の102.06%を占めています。2025Q3と比較して、機関の持ち株は-16.43%増加しています。

Cryoport Incの最大の収益源は何ですか?

FY2025Q3において、Life Science products部門がCryoport Incにとって最大の収益を生み出しており、その金額は19.98Mで、全収益の45.16%を占めています。
KeyAI